Sign In
Upcoming Event
Free Newsletter
NJBIZ Conversations: Protega Pharmaceuticals COO Paul Howe
Jeffrey Kanige//September 8, 2025//
Listen to this articleMany drugs, especially painkillers, can become dangerous in the wrong hands. Altering such medications can be a lucrative, though illegal, practice. Princeton-based Protega Pharmaceuticals has an answer.
The company focuses on producing abuse-deterrent pain management products. When applied to pills, for instance, the technology resists physical manipulation, chemical extraction and transformation for injection. Such products go a long way toward reducing substance abuse. In fact, the legislatures in both New Jersey and New York are pursuing measures that would require insurance companies to cover an abuse-deterrent medications if a physician prescribes it as needed.
In this edition of NJBIZ Conversations, Protega Chief Operating Officer Paul Howe describes the company’s products, its research and what the market looks like.
Watch the interview below:
Or just listen here instead:
